Shah Mihir has filed 8 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 151459 shares of Oncology Institute, Inc. ($TOI) on May 21, 2024.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | A | Common Stock | 151459 | $0.00 | 474,931.0000 | 76,046,694 | 46.82% | 0.20% |
| May 21, 2024 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 378648 | $0.00 | 378,648.0000 | 76,046,694 | 9999.99% | 0.50% |
| Dec. 14, 2023 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | P | Common stock | 99435 | $1.27 | 327,557.0000 | 73,265,621 | 43.59% | 0.14% |
| Dec. 14, 2023 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | P | Common stock | 565 | $1.25 | 328,122.0000 | 73,265,621 | 0.17% | 0.00% |
| May 23, 2023 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | D | Common Stock | 2573 | $0.43 | 224,341.0000 | 73,265,621 | 1.13% | 0.00% |
| May 23, 2023 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | D | Common Stock | 869 | $0.43 | 223,472.0000 | 73,265,621 | 0.39% | 0.00% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | A | Common stock | 176191 | $0.00 | 226,914.0000 | 73,265,621 | 347.36% | 0.24% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Shah Mihir | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 440477 | $0.00 | 440,477.0000 | 73,265,621 | 9999.99% | 0.60% |